|
Name |
Acaciicolinol G
|
Molecular Formula | C15H26O3 | |
IUPAC Name* |
(1R,2R,3R,6R)-9-(hydroxymethyl)-1,5,5-trimethylspiro[5.5]undec-9-ene-2,3-diol
|
|
SMILES |
C[C@H]1[C@H]([C@@H](CC([C@@]12CCC(=CC2)CO)(C)C)O)O
|
|
InChI |
InChI=1S/C15H26O3/c1-10-13(18)12(17)8-14(2,3)15(10)6-4-11(9-16)5-7-15/h4,10,12-13,16-18H,5-9H2,1-3H3/t10-,12+,13+,15-/m0/s1
|
|
InChIKey |
CZGPFTWSQIUAET-ZGFBFQLVSA-N
|
|
Synonyms |
Acaciicolinol G
|
|
CAS | NA | |
PubChem CID | 139590766 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 254.36 | ALogp: | 1.6 |
HBD: | 3 | HBA: | 3 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 60.7 | Aromatic Rings: | 2 |
Heavy Atoms: | 18 | QED Weighted: | 0.63 |
Caco-2 Permeability: | -4.697 | MDCK Permeability: | 0.00001050 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.028 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.963 |
30% Bioavailability (F30%): | 0.096 |
Blood-Brain-Barrier Penetration (BBB): | 0.195 | Plasma Protein Binding (PPB): | 86.01% |
Volume Distribution (VD): | 1.11 | Fu: | 20.16% |
CYP1A2-inhibitor: | 0.037 | CYP1A2-substrate: | 0.166 |
CYP2C19-inhibitor: | 0.016 | CYP2C19-substrate: | 0.766 |
CYP2C9-inhibitor: | 0.015 | CYP2C9-substrate: | 0.624 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.315 |
CYP3A4-inhibitor: | 0.048 | CYP3A4-substrate: | 0.108 |
Clearance (CL): | 4.166 | Half-life (T1/2): | 0.752 |
hERG Blockers: | 0.059 | Human Hepatotoxicity (H-HT): | 0.054 |
Drug-inuced Liver Injury (DILI): | 0.063 | AMES Toxicity: | 0.012 |
Rat Oral Acute Toxicity: | 0.04 | Maximum Recommended Daily Dose: | 0.023 |
Skin Sensitization: | 0.678 | Carcinogencity: | 0.054 |
Eye Corrosion: | 0.01 | Eye Irritation: | 0.855 |
Respiratory Toxicity: | 0.501 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003905 | 0.574 | D08PIQ | 0.274 | ||||
ENC003909 | 0.548 | D0KR5B | 0.266 | ||||
ENC003903 | 0.477 | D0D1SG | 0.266 | ||||
ENC003913 | 0.463 | D07DVK | 0.255 | ||||
ENC003907 | 0.455 | D0CW1P | 0.255 | ||||
ENC003908 | 0.455 | D0IT2G | 0.255 | ||||
ENC005118 | 0.433 | D0CZ1Q | 0.247 | ||||
ENC003912 | 0.412 | D0R7JT | 0.247 | ||||
ENC003911 | 0.412 | D0V9DZ | 0.247 | ||||
ENC003897 | 0.377 | D04VIS | 0.247 |